Synthesis and Structure—Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids

Journal of Medicinal Chemistry

Volumn 37, Issue 18, 1994, Pages 2930-2941

  Boehm, Marcus F ^a,b   Zhang, Lin ^a,b   Badea, Beth Ann ^a,b   White, Steven K ^a,b   Mais, Dale E ^a,b   Berger, Elaine ^a,b   Suto, Carla M ^a,b   Goldman, Mark E ^a,b   Heyman, Richard A ^a,b  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b Department of Medicinal Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; BEXAROTENE; CELL RECEPTOR; ETRETINATE; ISOTRETINOIN; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CONTROL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION REGULATION; GROWTH REGULATION; MONKEY; NONHUMAN; PSORIASIS; STRUCTURE ACTIVITY RELATION;

BENZOATES; BINDING, COMPETITIVE; GENE EXPRESSION REGULATION; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0028087742     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00044a014     Document Type: Article

References (31)

1. Orfanos, C. E.; Ehlert, R.; Gollnick, H. The Retinoids. A Review of Their Clinical Pharmacology and Therapeutic Use. Drugs 1987, 34, 459-503.
2. Smith, M. A.; Parkinson, D. R.; Cheson, B. D.; Friedman, M. A. Retinoids in Cancer Therapy. J. Clin. Oncol. 1992, 10, 839-864.
3. Vokes, E. E.; Weichselbaum, R. R.; Lippman, S. M.; Hong, W. K. Head and Neck Cancer. N. Engl. J. Med. 1993, 328, 184— 194.
4. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. The Retinoid Receptors. The Retinoids; Academic Press: Orlando, FL, 1994; pp 319-349.
5. Leid, M.; Kastner, P.; Chambon, P. Multiplicity Generates Diversity in the Retinoic Acid Signalling Pathways. Trends Biochem. Sci. 1992, 17, 427—433.
6. Hadicke, E.; Sporn, M.B. Structure-Activity Relationships of a New Series of Retinoidal Benzoic Acid Derivatives as Measured by Induction of Differentiation of Murine F9 Teratocarcinoma Cells and Human HL-60 Promyelocytic Leukemia Cells. Cancer Res., 1983, 43, 5268-5272.
7. Lippman, S. M.; Kessler, J. F.; Meyskens, F. L., Jr. Retinoids as Preventive and Therapeutic Anticancer Agents (Parts I and II). Cancer Treatment Reports; 1987, 71, No. 4, 391—405.
8. Lippman, S. M.; Kessler, J. F.; Meyskens, F. L., Jr. Retinoids as Preventive and Therapeutic Anticancer Agents (Parts I and II). Cancer Treatment Reports; 1987, 71, No. 5, 493-515.
9. Lehmann, J. M.; Jong, L.; Fanjul, A.; Cameron, J. F.; Lu, X. P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids Selective for Retinoid X Receptor Response Pathways. Science 1992, 258, 1944-1946.
10. Boehm, M. F.; Heyman, R. A.; Zhi, L. Compounds Having Selective Activity for Retinoid X Receptors, and Means for Modulation of Processes Mediated by Retinoid X Receptors. Eur. Pat. Appl. WO 93/21146, October 28, 1993.
11. Boehm, M. F.; McClurg, M. M.; Pathirana, C.; Mangelsdorf, D.; White, S. K.; Hebert, J.; Winn, D.; Goldman, M. E.; Heyman, R. A. Synthesis of High Specific Activity [3H]-9-cts Retinoic Acid and its Application for Identifying Retinoids with Unusual Binding Properties. J. Med. Chem. 1994, 37, 408-414.
12. Mangelsdorf, D. J.; Ong, E. S.; Dyck, J. A.; Evans, R. M. A Nuclear Receptor That Identifies a Novel Retinoic Acid Response Pathway. Nature 1990, 345, 224—229.
13. Berger, T. S.; Parandoosh, Z.; Perry, B. W.; Stein, R. B. Interaction of Glucocorticoid Analogues With the Human Glucocorticoid Receptor. J. Steroid Biochem. Mol. Biol. 1992, 41, 733-738.
14. Umesono, K.; Giguere, V.; Glass, C. K.; Rosenfeld, M. G.; Evans, R. M. Retinoic Acid and Thyroid Hormone Induce Gene Expression Through a Common Responsive Element. Nature 1988,336, 262-265.
15. Allegretto, E. A.; McClurg, M. R.; Lazarchik, S. B.; Clemm, D. L.; Kemer, S. A.; Elgort, M. G.; Boehm, M. F.; White, S. K.; Pike, J. W.; Heyman, R. A. Characterization and Comparison of Hormone-Binding and Transactivation Properties of Retinoic Acid and Retinoid X Receptors Expressed in Mammalian Cells and Yeast. J. Biol. Chem. 1993, 268, 26625-26633.
16. Maignan, J.; Lang, G.; Malle, G.; Restle, S.; Shroot, B. Bicyclic Aromatic Derivatives, Method for Preparing Them, and Their Use in Human and Veterinary Medicine and in Cosmetics. U.S. Patent 4,833,240, 1989.
17. Page, M. I. Entropy, Binding Energy and Enzyme Catalysis. Angew. Chem., Int. Ed. Engl. 1977, 16, 449-459.
18. Bruson, H. A.; Kroeger, J. W. Cycli-Alkylation of Aromatic Compounds by Friedel and Crafts Reaction. J. Am. Chem. Soc. 1940, 62, 36—44.
19. Staudinger, V. H.; Muntwyler, O.; Ruzicka, L.; Seibt, S. Insektentotende Stoffe VII. Synthesen der Chrysanthemumsaure und Anderer Trimethylencarbonsauren Mit Ungesattigter Seitenkette. Helv. Chim. Acta 1924, 7, 390-406.
20. Carpenter, M. S.; Easter, W. M.; Wood, T. F. Substituted Tetrahydronaphthalenes. U.S. Patent 2,897,237, 1959.
21. Giguere, V.; Ong, E. S.; Seul, P.; Evans, R. M. Identification of a Receptor for the Morphogen Retinoic Acid. Nature 1987, 330, 624-629.
22. Ishikawa, T.; Umesono, K.; Mangelsdorf, D. J.; Aburatani, H.; Stanger, B. Z.; Shibasaki, Y.; Imawari, M.; Evans, R. M.; Takaku, F. A Functional Retinoic Acid Receptor Encoded by the Gene Human Chromosome 12. Mol. Endocrinol. 1990, 4, 837-844.
23. Mangelsdorf, D. J.; Borgmeyer, U.; Heyman, R. A.; Zhou, J. Y.; Ong, E. S.; Oro, A. E.; Kakizuka, A.; Evans, R. M. Characterization of Three RXR Genes That Mediate the Action of 9-cis Retinoic Acid. Genes Devel. 1992, 6, 329-344.
24. Mangelsdorf, D. J.; Umesono, K.; Kliewer, S. A.; Borgmeyer, U.; Ong, E. S.; Evans, R. M. A Direct Repeat in the Cellular Retinolbinding Protein Type II Gene Confers Differential Regulation by RXR and RAR. Cell 1991, 66, 555-561.
25. Kliewer, S. A.; Umesono, K.; Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Evans, R. M. Retinoid X Receptor-COUP-TF Interactions Modulate Retinoic Acid Signaling. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 1448-1452.
26. Wigler, M.; Sweet, R.; Sim, G. K.; Wold, B.; Pellicer, A.; Lacy, E.; Maniatis, T.; Silverstein, S.; Axel, R. Transformation of Mammalian Cells With Genes From Procaryotes and Eucaryotes. Cell 1979,16, 777-785.
27. Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Stein, R. B.; Eichele, G.; Evans, R. M.; Thaller, C. 9-Cis Retinoic Acid as a High Affinity Ligand for Retinoid X Receptors. Cell 1992, 68, 397-406.
28. Summers, M. D.; Smith, G. E. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Tex., Agric. Exp. Stn., [Bull.] 1987, No. 155.
29. Wecksler, W. R.; Norman, A. W. An Hydroxylapatite Batch Assay for the Quantitation of 1a,25-Dihydroxyvitamin D3-Receptor Complexes. Anal. Biochem. 1979, 92, 314—323.
30. Cheng, Y.-C.; Prusoff, W. F. Relationship Between the Inhibition Constant (K,) and the Concentration of Inhibitor Which Causes 50% Inhibition (I50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
31. DeBlasi, A.; O'Reilly, K.; Motulsky, H. J. Calculating Receptor Number from Binding Experiments Using Same Compound as Radioligand and Competitor. TIPS 1989, 10, 227-229.